Cost of Revenue Comparison: Takeda Pharmaceutical Company Limited vs Xenon Pharmaceuticals Inc.

Takeda vs. Xenon: A Decade of Cost Dynamics

__timestamp	Takeda Pharmaceutical Company Limited	Xenon Pharmaceuticals Inc.
Wednesday, January 1, 2014	520990000000	5903000
Thursday, January 1, 2015	535405000000	2762000
Friday, January 1, 2016	558755000000	1114000
Sunday, January 1, 2017	495921000000	25573000
Monday, January 1, 2018	659690000000	6000000
Tuesday, January 1, 2019	1089764000000	38845000
Wednesday, January 1, 2020	994308000000	50523000
Friday, January 1, 2021	1106846000000	75463000
Saturday, January 1, 2022	1244072000000	105767000
Sunday, January 1, 2023	1431505000000	167512000
Monday, January 1, 2024	1431505000000

Unleashing the power of data

Cost of Revenue: A Tale of Two Pharmaceuticals

In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis compares the cost of revenue for Takeda Pharmaceutical Company Limited and Xenon Pharmaceuticals Inc. from 2014 to 2023. Takeda, a global leader, has seen its cost of revenue grow by approximately 175% over the decade, peaking at 1.43 trillion yen in 2023. In contrast, Xenon, a smaller player, experienced a more modest increase, with costs rising from 5.9 million to 167.5 million USD, reflecting its growth trajectory.

Key Insights

Takeda's Dominance: Takeda's cost of revenue consistently dwarfs Xenon's, highlighting its expansive operations.
Xenon's Growth: Despite its smaller scale, Xenon's cost of revenue increased by nearly 28 times, indicating significant expansion.
Missing Data: The absence of 2024 data for Xenon suggests potential reporting delays or strategic shifts.

Published by

U.S. Securities and Exchange Commission

Source link

sec.gov

Date published

17 Jan 2025

Similar Statistics

Cost Insights: Breaking Down Eli Lilly and Company and Xenon Pharmaceuticals Inc.'s Expenses

Amgen Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored

Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Takeda Pharmaceutical Company Limited

Analyzing Cost of Revenue: Takeda Pharmaceutical Company Limited and Cytokinetics, Incorporated

Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and Xenon Pharmaceuticals Inc.

Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Agios Pharmaceuticals, Inc.

Cost of Revenue Comparison: Biogen Inc. vs Xenon Pharmaceuticals Inc.

Analyzing Cost of Revenue: Bio-Techne Corporation and Xenon Pharmaceuticals Inc.

Cost Insights: Breaking Down BioMarin Pharmaceutical Inc. and Xenon Pharmaceuticals Inc.'s Expenses

Walgreens Boots Alliance, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored

Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.

Cost Insights: Breaking Down Xenon Pharmaceuticals Inc. and Vericel Corporation's Expenses